DS
GH icon

David Shaw’s Guardant Health GH Stock Holding History

David Shaw’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39M Hold
15,900
– – ﹤0.01% 3054
2026
Q1 		$1.47M Buy
+15,900
New +$1.6M ﹤0.01% 3154
2025
Q1 		– Sell
-14,700
Closed -$449K – 4427
2024
Q4 		$449K Sell
14,700
-2,200
-13% -$61.9K ﹤0.01% 3681
2024
Q3 		$388K Hold
16,900
– – ﹤0.01% 3844
2024
Q2 		$488K Hold
16,900
– – ﹤0.01% 3637
2024
Q1 		$349K Buy
+16,900
New +$362K ﹤0.01% 3663
2023
Q3 		– Sell
-11,800
Closed -$422K – 4334
2023
Q2 		$422K Buy
+11,800
New +$339K ﹤0.01% 3486

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

David Shaw's GH Position: Q2 2026 in Review

David Shaw increased its Guardant Health (GH) stake by 194% in Q2 2026, buying an estimated $90.1M and bringing the position to 1,255,658 shares worth $188M. The position accounts for 0.09% of the portfolio, ranked #235.

David Shaw first reported a position in GH in Q1 2020 and has held it in 15 quarters since. 595 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • David Shaw held 1,255,658 shares of Guardant Health worth $188M as of Q2 2026.
  • David Shaw bought 828,183 Guardant Health shares in Q2 2026, an estimated $90.1M.
  • Guardant Health made up 0.09% of David Shaw's portfolio in Q2 2026, its #235 holding.
  • David Shaw first reported a position in Guardant Health in Q1 2020 and has held it in 15 quarters since.
  • 595 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.